metagenomics
Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test
The partners will collaborate to develop novel microbiome biomarkers for a screening test in development called PancAlert.
At ASCO, Biomarker Strategies Show Potential for Guiding Metastatic Pancreatic Cancer Treatment
Premium
Two studies presented Friday suggested that biomarker-selected approaches could improve patient outcomes on immunotherapy and targeted therapy.
Microbiotica Advancing Bacterial Signature to Improve Immunotherapy Response, Patient Selection
Premium
The firm is developing an oral capsule of live bacteria to improve response rates to checkpoint inhibitors and advancing a predictive test relying on the same bacterial signature.
The proof-of-principle study demonstrated the feasibility of altering the microbiome to elicit anti-PD-1 response and shed light on which patients might benefit.
Startup Using Omics Analysis in Large Microbiome Study to Inform Cancer Therapy, CDx Development
Premium
Persephone Biosciences has launched a prospective, longitudinal study to evaluate 4,000 patients' gut microbiomes and link them with cancer treatment response.